Item request has been placed!

Item request cannot be made.

Processing Request

Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ أكثر حفظ في قائمتي

المؤلفون: Jhund, PS; Fu, M; Bayram, E; Chen, C-H; Negrusz-Kawecka, M; Rosenthal, A; Desai, AS; Lefkowitz, MP; Rizkala, AR; Rouleau, JL; Shi, VC; Solomon, SD; Swedberg, K; Zile, MR; McMurray, JJV; Packer, M
المصدر:
2584 ; 2576
الموضوع:
Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; Heart failure; Neprilysin; Receptors; Angiotensin; Age; SYSTOLIC HEART-FAILURE; CLINICAL-TRIALS; NEPRILYSIN INHIBITION; ENALAPRIL; COMORBIDITIES; MANAGEMENT; MORTALITY; PROGRAM; RISK; Adolescent; Adult; Age Factors; Aged; 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Cause of Death; Humans; Middle Aged; Tetrazoles; Treatment Outcome
نوع التسجيلة:
article in journal/newspaper
اللغة:
unknown

معلومة اضافية
- بيانات النشر:
  Oxford University Press
- الموضوع:
  2015
- Collection:
  Imperial College London: Spiral
- ISSN:
  1522-9645
- Relation:
  European Heart Journal; http://hdl.handle.net/10044/1/41859; http://dx.doi.org/10.1093/eurheartj/ehv330
- الرقم المعرف:
  10.1093/eurheartj/ehv330
- Rights:
  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
- الرقم المعرف:
  edsbas.5E149A8A

تعليقات

No Comments.